NDC 51655-022

OMEPRAZOLE DR

Omeprazole Dr

OMEPRAZOLE DR is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Omeprazole.

Product ID51655-022_ed3d5067-3b30-45fc-a813-791eda993b5e
NDC51655-022
Product TypeHuman Prescription Drug
Proprietary NameOMEPRAZOLE DR
Generic NameOmeprazole Dr
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2014-10-27
Marketing CategoryANDA / ANDA
Application NumberANDA076048
Labeler NameNorthwind Pharmaceuticals, LLC
Substance NameOMEPRAZOLE
Active Ingredient Strength20 mg/1
Pharm ClassesProton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-022-25

60 CAPSULE, DELAYED RELEASE in 1 BOTTLE, DISPENSING (51655-022-25)
Marketing Start Date2014-10-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-022-25 [51655002225]

OMEPRAZOLE DR CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA076048
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-09
Inactivation Date2020-01-31

NDC 51655-022-26 [51655002226]

OMEPRAZOLE DR CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA076048
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-10-27
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
OMEPRAZOLE20 mg/1

OpenFDA Data

SPL SET ID:78a623e8-47be-44b6-b7e0-5b13b2bcecf9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198051
  • Pharmacological Class

    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    NDC Crossover Matching brand name "OMEPRAZOLE DR" or generic name "Omeprazole Dr"

    NDCBrand NameGeneric Name
    61919-176OMEPRAZOLE DROMEPRAZOLE DR
    61919-773OMEPRAZOLE DROMEPRAZOLE DR
    61919-807OMEPRAZOLE DROMEPRAZOLE DR
    51655-022OMEPRAZOLEOMEPRAZOLE DR

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.